spacer
home > ebr > winter 2018 > training day
PUBLICATIONS
European Biopharmaceutical Review

Training Day

As opposed to traditional pharmaceutical products, biopharmaceuticals are complex high-molecular-weight items of biological origin derived from living organisms, cells, animals or plants. Market predictions strongly suggest that sales of biopharmaceutical products will continue to increase year-on-year, with the market being driven primarily by further increases in sales of recombinant monoclonal antibodies (mAbs) that have proven to be successful therapies for a large number of disease states.

However, the focus on advanced therapy medicinal products is increasing, with some manufacturers looking to diversify into gene therapies, cell therapies and tissue engineering as strategies for pipeline development. By 2020, biopharma sales are estimated to contribute at least 50% of total biopharma and pharma revenues, with the former contributing 80% of product candidates in pipelines (1).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr John Milne is currently Director of training at the National Institute for Bioprocessing Research and Training. He has been employed in the biopharma industry for 20 years and has performed in a series of roles, including process development, optimisation, scale-up and GMP manufacture of therapeutic proteins and mAbs in regulated facilities. John received his PhD in molecular enzymology from the Department of Biochemistry at University College Dublin.
spacer
Dr John Milne
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Announces Expansion of its Industry-Leading Cold Chain Infrastructure with Dedicated Minus 40 degrees C Facility

Philadelphia, USA August 29, 2018 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, Clinical trial services, and commercial packaging to the global healthcare industry, is pleased to announce the completion of a purpose built -40C storage and distribution facility at its North American Clinical Services Center of Excellence.
More info >>

White Papers

Smaller, Smarter, Electronic, Connected: The Next Generation of Drug-Delivery Devices

Phillips-Medisize

An exciting trend in drug delivery is underway: the movement toward smaller, smarter, wirelessly connected electronic devices that allow patient-administered therapy. Inspired by the technological advancements driving the consumer electronics market, new methods for drug delivery show great promise for all stakeholders. Patients wishing to claim more autonomy over their drug regimens, caregivers and medical professionals wanting to more closely monitor drug compliance, health insurance organizations looking to keep costs down, and developers of pharmaceutical products interested in conducting better managed clinical trials can all benefit from these novel, next-generation technologies.
More info >>

 
Industry Events

RDD Asia 2018

14-15 November 2018, Grand Hyatt Kochi, Kerala, India

A must-attend meeting for pulmonary and nasal researchers, inhaled product developers and vendors active in this important pharmaceutical niche.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement